SEC Form 4 · accession 0001041889-15-000018
PSYCHEMEDICS CORP · PMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James V. Dyke
Officer — Vice President - Sales
Period of report
May 22, 2015
Accepted (ET)
May 27, 2015 · 1:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000806517
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.005 Par Value | May 22, 2015 | F | 936 | $14.64 | D | 40,657 | D | |
| Common Stock, $.005 Par Value | May 23, 2015 | F | 795 | $14.64 | D | 39,862 | D | |
| Common Stock, $.005 Par Value | May 24, 2015 | F | 749 | $14.64 | D | 39,113 | D |
Table II — derivative securities
No Table II lines on this filing.